Trading Ideas
Hell is Coming: Here is the Mathematical Proof
Executive Summary Right now 2 million Americans are infected with the coronavirus. The total U.S. death toll by April 15th will be more than 20,000. We estimate that 80 thousand of the 2 million infected Americans will be hospitalized over the next 2 weeks. That’s why we are short-term bullish on hospital stocks. Thesis: Everything I […] …read more […]
Italy Hits Record Deaths; N.Y. Sends Workers Home; Virus Update
(Bloomberg) — New York State ordered all non-essential workers to stay home. Italy reported 627 deaths, the most in one day, as the toll in Europe’s epicenter topped 4,000.President Donald Trump banned all non-essential travel from Mexico, exempting commerce. He also deferred student loan payments.The U.K. and the U.S. warned that social distancing may be in place longer than expected as the pace of coronavirus infections picked up. The European Union said the looming recession may be much worse than previously anticipated.It took three months for the first 100,000 cases but only 12 days for the next 100,000. The pathogen …read more […]
‘No Stock Buybacks’ Demands Trump
President Trump and Senator Chuck Schumer met this week to discuss a number of pressing issues. One of them…stock buybacks.
“I am fine with restricting buybacks. In fact, I would demand that there be no stock buybacks. I don’t want them taking hundreds of millions of dollars and buying back their stock.” – President Trump
What Is A Stock Buyback?
A stock buyback or “share repurchase” is the re-acquisition by a company of its own stock. It represents a more flexible way (relative to dividends) of returning money to shareholders.
A stock buyback allows a company to re-invest in itself. The shares are re-purchased …read more […]
McConnell’s $1T relief plan would put $1,200 in tax payers’ pockets
Edelman Financial Engines Founder Ric Edelman breaks down the details of McConnell’s $1 trillion coronavirus relief plan, with Yahoo Finance’s Zack Guzman. …read more […]
Fmr. CDC official: coronavirus testing ‘should’ve started months ago’
The number of COVID-19 cases has surged to over 200K globally. Former Center for Disease Control and Prevention Epidemic Intelligence Officer Dr. Rishi Desai joins Yahoo Finance’s Zack Guzman to discuss. …read more […]
The Good News About the Coronavirus
By now you’ve heard a lot of bad news about COVID-19, but things are already looking up.
Today, Alexander Green shares some good news and talks about why wealth builders should focus on the positive.
You’ve already heard most of the bad news about the coronavirus.
It’s highly transmissible. No one is immune. The mortality rate is unsettling, especially for the elderly. There is no successful treatment or vaccine. We are woefully behind in testing. Cases are growing exponentially. And our healthcare system is not equipped to deal with it.
Most Americans have gotten the message and are staying at home or social distancing …read more […]
Hedge Funds Have Never Been This Bullish On Arrowhead Pharmaceuticals, Inc. (ARWR)
Coronavirus is probably the 1 concern in investors’ minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […] …read more […]
Hedge Funds Were Flocking Into Moderna, Inc. (MRNA) Before The Coronavirus
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […] …read more […]
‘We are in a global recession’: Mohamed El-Erian
Allianz Chief Economic Adviser Mohamed El-Erian says, “we are in a global recession” as the coronavirus continues to spread across the world. He joins Yahoo Finance’s On The Move panel to discuss. …read more […]
Gilead’s Coronavirus Vaccine Candidate Shows Promise, Says Cowen
After falling for three straight years on declining sales of hepatitis C drugs, Gilead Sciences’ (GILD) revenues finally seemed to bottom last year, and even resumed growing again. Now there’s hope that the global coronavirus pandemic could give Gilead an additional financial shot in the arm in 2020 and beyond.In a note surveying the “medical view from the front lines” on COVID-19 developments, Cowen analyst Steve Scala sketched out what one hopes will turn out to be the worst case scenario for coronavirus in the U.S.: Peak infections of 100,000 patients — a bit more than China suffered during its …read more […]
Here's a list of CEOs taking pay cuts amidst the coronavirus crisis
Many industries have been slammed by coronavirus social distancing efforts. As the revenue trickles to zero, some CEOs are taking pay cuts. …read more […]
President Trump, coronavirus task force deliver update on COVID-19 response
Yahoo Finance’s Rick Newman joins the On The Move panel to weigh in on the latest coronavirus developments. …read more […]
AT&T stops share repurchase plans in response to COVID-19 outbreak
AT&T Inc withdrew plans to repurchase $4 billion in common stock as it was unable to predict the impact of the coronavirus outbreak on its business, the company said on Friday in a regulatory filing. Shares of AT&T fell 8% in midday trade. AT&T said it planned to continue investing in its network and taking care of its employees. …read more […]
